Management approach to patients with premalignant lesions of the stomach
Abstract
The aim of review. To analyze modern aspects of management of patients with premalignant changes in the stomach.
Key points. According to requirements of system OLGA or OLGIM application of modern endoscopic methods and morphological investigation is necessary for expert diagnostics of atrophy, metaplasia and dysplasia in the stomach. Detection of Helicobacter pylori infection and its eradication are important principles of management of patients with stomach premalignant lesions.
Conclusion. Monitoring methods of patients with stomach mucosa dysplasia are specified. Modes of H. pylori eradication are presented.
Keywords
About the Authors
V. V. Tsukanov
Federal State Budgetary Institution «Scientific research institute of medical problems of the North» Siberian branch, Russian Academy of Medical Science
Russian Federation
Russian Federation
O. S. Amelchugova
Federal State Budgetary Institution «Scientific research institute of medical problems of the North» Siberian branch, Russian Academy of Medical Science
Russian Federation
Russian Federation
A. V. Vas'yutin
Federal State Budgetary Institution «Scientific research institute of medical problems of the North» Siberian branch, Russian Academy of Medical Science
Russian Federation
Russian Federation
N. N. Butorin
Remishevskaya Khakass republic hospital
Russian Federation
Russian Federation
References
1. Ивашкин В.Т., Маев И.В., Лапина Т.Л. и др. Рекомендации Российской Гастроэнтерологической Ассоциации по диагностике и лечению инфекции Helicobacter pylori у взрослых // Рос. журн. гастроэнтерол. гепатол. колопроктол. – 2012. – Т. 22, № 1. – С. 87–89.
2. Осипенко М.Ф., Бикбулатова Е.А., Шакалите Ю.Д., Чернова Л.Н. Резистентность Helicobacter pylori к кларитрмицину в Новосибирске // Рос. журн. гастроэнтерол. гепатол. колопроктол. – 2012. – Т. 12, № 5, прил. 40. – С. 36.
3. Перфилова К.М., Неумоина Н.В., Неумоина М.В. и др. Изучение резистентности H. pylori к макролидам у больных с хроническими заболеваниями желудка и двенадцатиперстной кишки // Рос. журн. гастроэнтерол. гепатол. колопроктол. – 2012. –Т. 12, № 5, прил. 40. – С. 37.
4. Цуканов В.В., Третякова О.В., Амельчугова О.С. и др. Распространенность атрофического гастрита тела желудка у населения г. Красноярска старше 45 лет // Рос. журн. гастроэнтерол. гепатол. колопроктол. – 2012. – Т. 12, № 4. – С. 27–31.
5. Areia M., Amaro P., Dinis-Ribeiro M. et al. External validation of a classification for methylene blue magnification chromoendoscopy in premalignant gastric lesions // Gastrointest. Endosc. – 2008. – N 67. – P. 1011–1018.
6. Bah A., Saraga E., Armstrong D. et al. Endoscopic features of Helicobacter pylori-related gastritis // Endoscopy. – 1995. – N 27. – P. 593–596.
7. Capelle L.G., de Vries A.C., Haringsma J. et al. The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis // Gastrointest. Endosc. – 2010. – N 71. – P. 1150–1158.
8. Correa P. A human model of gastric carcinogenesis // Cancer Res. – 1988. – N 48. – P. 3554–3560.
9. Correa, P., Sherlock P., Morson B. Chronic atrophic gastritis as a precursor of cancer // Precancerous lesions of the gastrointestinal tract. – New York: Raven Press, 1983. – Р. 145–153.
10. Dai W.Q., Zhou Y.Q., Xu L. et al. The eradicating Helicobacter pylori infection in duodenal ulcer patients by three short-term triple therapies in China: a multicenter clinical comparative study // Hepatogastroenterology. – 2012. – Vol. 59, N 113. – P. 296–299.
11. De Vries A.C., Haringsma J., de Vries R.A. et al. Biopsy strategies for endoscopic surveillance of premalignant gastric lesions // Helicobacter. – 2010. – N 15. – P. 259–264.
12. Dinis-Ribeiro M. Chromoendoscopy for early diagnosis of gastric cancer // Eur. J. Gastroenterol. Hepatol. – 2006. – Vol. 18, N 8. – P. 831–838.
13. Dinis-Ribeiro M., Areia M., de Vries A.C. et al. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED) // Endoscopy. – 2012. – Vol. 44, N 1. – P. 74–94.
14. Dinis-Ribeiro M., Yamaki G., Miki K. et al. Metaanalysis on the validity of pepsinogen test for gastric carcinoma, dysplasia or chronic atrophic gastritis screening // J. Med. Screen. – 2004. – N 11. – P. 141–147.
15. El-Zimaity H.M., Ota H., Graham D.Y. et al. Patterns of gastric atrophy in intestinal type gastric carcinoma // Cancer. – 2002. – N 94. – Р. 1428–1436.
16. Eshmuratov A., Nah J.C., Kim N. et al. The correlation of endoscopic and histological diagnosis of gastric atrophy // Dig. Dis. Sci. – 2010. – N 55. – P. 1364–1375.
17. Ferlay J., Shin H.R., Bray F. et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 // Int. J. Cancer. – 2010. – N 127. – P. 2893–2917.
18. Fujioka T., Aoyama N., Sakai K. et al. A large-scale nationwide multicenter prospective observational study of triple therapy using rabeprazole, amoxicillin, and clarithromycin for Helicobacter pylori eradication in Japan // J. Gastroenterol. – 2012. – Vol. 47, N 3. – P. 276–283.
19. Gisbert J.P., Calvet X. Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enough // Aliment. Pharmacol. Ther. – 2011. – Vol. 34, N 11. – P. 1255–1268.
20. Guarner J., Herrera-Goepfert R., Mohar A. et al. Diagnostic yield of gastric biopsy specimens when screening for preneoplastic lesions // Hum. Pathol. – 2003. – N 34. – P. 28–31.
21. Hirata I., Nakagawa Y., Ohkubo M. et al. Usefulness of magnifying narrow-band imaging endoscopy for the
22. diagnosis of gastric and colorectal lesions // Digestion. – 2012. – Vol. 85, N 2. – P. 74–79.
23. Kosunen T.U., Pukkala E., Sarna S. et al. Gastric cancers in Finnish patients after cure of Helicobacter pylori infection: A cohort study // Int. J. Cancer. – 2011. – Vol. 128, N 2. – P. 433–439.
24. Lee B.E., Kim G.H., Park Y. et al. Acetic acid-indigo carmine chromoendoscopy for delineating early gastric cancers: its usefulness according to histological type // BMC Gastroenterol. – 2010. – N 10. – P. 97.
25. Malfertheiner P., Megraud F., O′Morain C. et al. Current concepts in the management of Helicobacter pylori infection – The Maastricht 2–2000 Consensus Report // Aliment. Pharmacol. Ther. – 2000. – Vol. 16, N 2. – P. 167–180.
26. Malfertheiner P., Megraud F., O′Morain C. et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report // Gut. – 2007. – Vol. 56, N 6. – P. 772–781.
27. Malfertheiner P., Megraud F., O′Morain C. et al. Management of Helicobacter pylori infection: the Maastricht IV/ Florence Consensus Report // Gut. – 2012. – Vol. 61, N 7. – P. 646–664.
28. Matsuzaka M., Fukuda S., Takahashi I. et al. The decreasing burden of gastric cancer in Japan // Tohoku. J. Exp. Med. – 2007. – Vol. 212, N 3. – P. 207–219.
29. Redéen S., Petersson F., Jönsson K.A. et al. Relationship of gastroscopic features to histological findings in gastritis and Helicobacter pylori infection in a general population sample // Endoscopy. – 2003. – N 35. – P. 946–950.
30. Rugge M., Correa P., di Mario F. et al. OLGA staging for gastritis: a tutorial // Dig. Liver Dis. – 2008. – Vol. 40, N 8. – P. 650–658.
31. Rugge M., Farinati F., Baffa R. et al. Gastric epithelial dysplasia in the natural history of gastric cancer: a multicenter prospective follow-up study. Interdisciplinary Group on Gastric Epithelia Dysplasia // Gastroenterology. – 1994. – N 107. – P. 1288–1296.
32. Tanaka K., Toyoda H., Kadowaki S. et al. Surface pattern classification by enhanced magnification endoscopy for identifying early gastric cancers // Gastrointest. Endosc. – 2008. – N 67. – P. 430–437.
33. Tepes B., O′Connor A., Gisbert J., O′Morain C. Treatment of Helicobacter pylori infection 2012 // Helicobacter. – 2012. – Vol. 17, suppl. 1. – P. 36–42.
34. Tsukanov V.V., Butorin N.N., Maady A.S. et al. Helicobacter pylori infection, intestinal metaplasia, and gastric cancer risk in Eastern Siberia // Helicobacter. – 2011. – Vol. 16, N 2. – P. 107–112.
35. Vannella L., Lahner E., Osborn J. et al. Risk factors for progression to gastric neoplastic lesions in patients with atrophic gastritis // Aliment. Pharmacol. Ther. – 2010. – N 31. – P. 1042–1050.
36. Villoria A. Acid-related diseases: are higher doses of proton pump inhibitors more effective in the treatment of Helicobacter pylori infection? // Gastroenterol. Hepatol. – 2008. – Vol. 31. – P. 546–547.
37. Zivny J., Wang T.C., Yantiss R. et al. Role of therapy or monitoring in preventing progression to gastric cancer // Clin. Gastroenterol. – 2003. – Vol. 36, suppl. 1. – P. 52–60.
Review
For citations:
Tsukanov V.V., Amelchugova O.S., Vas'yutin A.V., Butorin N.N. Management approach to patients with premalignant lesions of the stomach. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2013;23(3):4-8. (In Russ.)
Views:
113
Email this article 
